Eugene Braunwald
0000-0002-3472-626X
27 papers found
Refreshing results…
Prognostic Importance of NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Following High-Risk Myocardial Infarction in the PARADISE-MI Trial
The Effects of Angiotensin Receptor-Neprilysin Inhibition on Major Coronary Events in Patients With Acute Myocardial Infarction: Insights From the PARADISE-MI Trial
Cardiac xenotransplantation: a new path for the treatment of advanced heart failure?
Gliflozins in the Management of Cardiovascular Disease
Cardiac cell therapy: a call for action
Heart failure: a 70 year Odyssey
Cardiovascular Events and Long‐Term Risk of Sudden Death Among Stabilized Patients After Acute Coronary Syndrome: Insights From IMPROVE‐IT
Ischaemic and bleeding risk in atrial fibrillation with and without peripheral artery disease and efficacy and safety of full- and half-dose edoxaban vs. warfarin: insights from ENGAGE AF-TIMI 48
SGLT2 inhibitors: the statins of the 21st century
A tribute to Attilio Maseri
Heart failure with preserved ejection fraction: a stepchild no more!
How to live to 100 before developing clinical coronary artery disease: a suggestion
Cholesterol: the race to the bottom
Reflections on Hypertrophic Cardiomyopathy
Transseptal left heart catheterization: birth, death, and resurrection
The Birth of Cardiology: The Golden Decade
Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial
Sex, Permanent Drug Discontinuation, and Study Retention in Clinical Trials
Predictors, Type, and Impact of Bleeding on the Net Clinical Benefit of Long‐Term Ticagrelor in Stable Patients With Prior Myocardial Infarction
Cardiology in 2021
Missing publications? Search for publications with a matching author name.